Photo from EORTC/X
Jul 14, 2024, 22:08
The primary endpoint has been reached in the EORTC-1333-GUCG/PEACE III Trial
EORTC (European Organisation for Research and Treatment of Cancer) shared a post on X:
”EORTC is pleased to announce that the primary endpoint has been reached in the EORTC-1333-GUCG/PEACE III Trial.”
Source: EORTC/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 00:19
Nov 14, 2024, 00:02
Nov 13, 2024, 23:57
Nov 13, 2024, 23:54
Nov 13, 2024, 23:48
Nov 13, 2024, 23:46